Highlights in Kidney Cancer From the 2016 American Society of Clinical Oncology Annual Meeting

Clinical Advances in Hematology & Oncology Volume 14, Issue 8, August 2016 Highlights in Kidney Cancer From the 2016 American Society of Clinical Oncology Annual Meeting […]

The Science of Checkpoint Inhibition in Kidney Cancer

Clinical Advances in Hematology & Oncology April 2016, Volume 14, Issue 4 Based on a presentation by Gordon J. Freeman, PhD, at the ASCO Genitourinary Cancers […]

Combination Immunotherapy in Renal Cell Carcinoma

Clinical Advances in Hematology & Oncology February 2016, Volume 14, Issue 2 Based on a presentation by Charles G. Drake, MD, PhD, at the Kidney Cancer […]

The Right Questions to Ask in New Trials of Immunotherapy

Clinical Advances in Hematology & Oncology December 2015, Volume 13, Issue 12 Based on a presentation by David McDermott, MD, at the Kidney Cancer Symposium Now […]

Lenvatinib/Everolimus Improves Survival Better Than Everolimus Alone in Metastatic Renal Cell Cancer

Clinical Advances in Hematology & Oncology August 2015, Volume 13, Issue 8 Based on a presentation by Robert Motzer, MD, at the American Society of […]

The Future of Kidney Cancer Treatment

Volume 13, Issue 6 June 2015 Daniel J. George, MD Associate Professor of Medicine and Surgery Director of Genitourinary Oncology Program Department of Medicine Duke University […]